US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.41

+0.01000.00%

Post-market: 252.401.99+0.79%19:58 EDT

Volume:217.35K

Turnover:55.00M

Market Cap:494.43M

PE:- -

High:259.83

Open:253.12

Low:242.96

Close:250.40

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.83

T/O Rate:11.01%

Dividend:1.00

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

UMP Healthcare Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend

Apeloa Pharma's Subsidiary Secures FDA Nod for Brivaracetam Tablets

U.S. FDA Grants Priority Review to Takeda Pharmaceutical's Zasocitinib NDA for Plaque Psoriasis

MT Newswires Live

Takeda's Investigational Plaque Psoriasis Drug Accepted for Priority Review by US FDA

MT Newswires Live

Scholar Rock Gets FDA Approval for Spinal Muscular Atrophy Treatment in Children, Adults; Shares Up Pre-Bell

MT Newswires Live

Health Care Roundup: Market Talk

Brown Advisory US Smaller Companies Trust Reveals August Portfolio Tilt Toward Industrials, Healthcare and Tech

OPT S.P.A. Wins €138K Haematology Event Contract to Boost 2026 Revenue

Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care

Humanwell Healthcare Gets China Nod for Phloroglucinol Tablets

MT Newswires Live

Yantai Dongcheng Pharmaceutical's Sino Siam Biotechnique Gets US FDA's EIR After Inspection

MT Newswires Live

Aurobindo Pharma's API Unit Gets Zero Observations From US FDA

MT Newswires Live

Fisher & Paykel Healthcare Lists Additional Shares on ASX as Foreign Exempt NZX Securities

ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles

MT Newswires Live

Malaysia's Healthcare Sector Could Remain Resilient in 2H

Regis Healthcare Director Increases Indirect Shareholding

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Scholar Rock Holding (SRRK) and Danaher (DHR)

HealthCo Healthcare and Wellness REIT Says Healthscope Lender Support Obtained for Transfer of 10 Hospitals

MT Newswires Live

Wall Street Analysts Are Bullish on Top Healthcare Picks

160 Health Expands into Integrated Healthcare and AI Computing Solutions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.41,"timestamp":1789588800000,"preClose":250.4,"halted":0,"volume":217354,"hourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"delay":0,"changeRate":0.000039936102236385406,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Closed","change":0.01,"latestTime":"09-16 16:00:00 EDT","open":253.12,"high":259.83,"low":242.96,"amount":54997599.92252,"amplitude":0.067372,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.4,"sharesOutstanding":3074486,"nav":250.283,"aum":494179857.69,"dividendRate":0.004,"bidAskSpread":0.002806,"preHourTrading":{"tag":"盘前","latestPrice":254.8128,"preClose":250.4,"latestTime":"09:28 EDT","volume":4289,"amount":1082884.5326099999,"timestamp":1789565312693,"change":4.4128,"changeRate":0.017623,"amplitude":0.012511},"postHourTrading":{"tag":"盘后","latestPrice":252.4,"preClose":250.41,"latestTime":"19:58 EDT","volume":3855,"amount":968174.9559,"timestamp":1789603104098,"change":1.99,"changeRate":0.007947,"amplitude":0.007947},"volumeRatio":0.831749,"impliedVol":0.9487,"impliedVolPercentile":0.6773},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.831749,"shares":1974486,"dividePrice":1.0016,"high":259.83,"amplitude":0.067372,"preClose":250.4,"low":242.96,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.41,"eps":0,"divideRate":0.004,"volume":217354,"delay":0,"ttmEps":0,"open":253.12,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":279.02,"twentyDayClose":289.98,"sixtyDayClose":230.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667654572","title":"UMP Healthcare Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654572?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:09","pubTimestamp":1789376973,"startTime":"0","endTime":"0","summary":"UMP Healthcare Holdings Limited ( ($HK:0722) ) just unveiled an announcement. UMP Healthcare Holdings Limited has scheduled a board meeting for 24 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ump-healthcare-sets-board-meeting-to-approve-2026-annual-results-and-consider-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ump-healthcare-sets-board-meeting-to-approve-2026-annual-results-and-consider-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","BK4137","BK4588","LU0029874061.USD","HCSG","XLV","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123614423","title":"Apeloa Pharma's Subsidiary Secures FDA Nod for Brivaracetam Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1123614423","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123614423?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:58","pubTimestamp":1789376302,"startTime":"0","endTime":"0","summary":"Apeloa Pharmaceutical Co.,Ltd. (000739.SZ) has announced that its wholly-owned subsidiary, Zhejiang Apeloa Jutai Pharmaceutical Co., Ltd. (\"Jutai Pharma\"), has received notification from the U.S....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000739","LABU","BK0060","BK4588","BK0188","BK0239","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765158","title":"U.S. FDA Grants Priority Review to Takeda Pharmaceutical's Zasocitinib NDA for Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765158","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765158?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:50","pubTimestamp":1789375847,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  accepted Takeda Pharmaceutical's  new drug application  for zasocitinib under priority review for adults with moderatetosevere plaque psoriasis, according to a Monday filing with the Japanese bourse.The application is supported by Phase III LATITUDE PsO 3001 and 3002 trials, which met all primary and ranked secondary endpoints. About 70% of patients achieved clear or nearly clear skin by Week 16, with improvements seen from Week 4 and sustained through Week 52, the filing said.Shares of Takeda Pharmaceutical added over 1% at market close.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667722659","title":"Takeda's Investigational Plaque Psoriasis Drug Accepted for Priority Review by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667722659","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667722659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:42","pubTimestamp":1789375339,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  investigational zasocitinib's new drug application for the treatment of adults with moderate-to-severe plaque psoriasis has been accepted for priority review by the US Food and Drug Administration, the company said Monday.The drug showed \"rapid, durable and consistent\" skin clearance in a phase 3 trial involving nearly 3,000 patients, the company said.Shares of the company were up 4.1% in premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4588","BK4007","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643659","title":"Scholar Rock Gets FDA Approval for Spinal Muscular Atrophy Treatment in Children, Adults; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643659","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374609,"startTime":"0","endTime":"0","summary":"Scholar Rock  has received US Food and Drug Administration approval for Isembyld to treat spinal muscular atrophy in certain patients aged two years and above, the company said Friday.Isembyld is expected to ship in the coming days, Scholar Rock said, adding that the company has received a rare pediatric disease priority review voucher that may be used to obtain priority review for a future marketing application.Spinal muscular atrophy is a severe neuromuscular disease that leads to an irreversible loss of motor neurons and progressive muscle wasting.Scholar Rock shares were up 8.6% in premarket activity Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4139","IBRN","SRRK","THNR","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659374","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659374?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:20","pubTimestamp":1789374000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0740 GMT - Innovent Biologics' enlarged cash holdings and invest","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0577902538.SGD","SG9999002620.SGD","XBI","SGXZ58947870.SGD","LU2506951875.HKD","BK6112","SG9999008742.SGD","LU1282649067.USD","SG9999003925.USD","LU0441854154.USD","LABU","LU0630378692.HKD","LU0128522157.USD","LU1770036033.HKD","LU0823397103.USD","LU3227948356.SGD","LU0326948709.USD","LU0823397285.USD","SG9999014302.SGD","LU0630378429.USD","LU2506952170.USD","LU0955648018.USD","XLV","LU1130305938.SGD","LU0192582467.USD","LU0823417737.USD","LU1497733631.SGD","SG9999005177.SGD","LU0043850808.USD","SG9999003826.SGD","SG9999013486.USD","LU0384037296.USD","LU2152927971.USD","SG9999001903.USD","LU0345776255.USD","D05.SI","LU0831093199.SGD","SG9999011175.SGD","LU0188438112.USD","SG9999014492.USD","LU0197773673.USD","SG9999004360.SGD","SGXZ27511609.SGD","SGXZ51708014.SGD","LU0205439572.USD","LU0210637038.USD","LU0886674414.USD","LU0588545490.SGD","SGXZ43160589.SGD","SGXZ44547263.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667595886","title":"Brown Advisory US Smaller Companies Trust Reveals August Portfolio Tilt Toward Industrials, Healthcare and Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2667595886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667595886?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:02","pubTimestamp":1789372945,"startTime":"0","endTime":"0","summary":"An update from Brown Advisory US Smaller Companies PLC GBP ( ($GB:BASC) ) is now available. Brown Advisory US Smaller Companies PLC has published i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brown-advisory-us-smaller-companies-trust-reveals-august-portfolio-tilt-toward-industrials-healthcare-and-tech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brown-advisory-us-smaller-companies-trust-reveals-august-portfolio-tilt-toward-industrials-healthcare-and-tech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4588","LU0128526141.USD","BK4137","XLV","BK4585","LABU","HCSG","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667665502","title":"OPT S.P.A. Wins €138K Haematology Event Contract to Boost 2026 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665502","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667665502?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:32","pubTimestamp":1789371144,"startTime":"0","endTime":"0","summary":"OPT S.P.A. ( ($IT:OPTS) ) has shared an update. OPT S.P.A., listed as OPTS:IM, is an Italian provider of High Value-Added Healthcare Services that ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/opt-s-p-a-wins-e138k-haematology-event-contract-to-boost-2026-revenue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/opt-s-p-a-wins-e138k-haematology-event-contract-to-boost-2026-revenue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","XBI","XLV","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667550436","title":"Takeda’s Zasocitinib Wins FDA Priority Review in Bid to Redefine Oral Psoriasis Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2667550436","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667550436?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:28","pubTimestamp":1789370888,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an update. Takeda has secured U.S. FDA Priority Review for its New Drug Application for zasoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-zasocitinib-wins-fda-priority-review-in-bid-to-redefine-oral-psoriasis-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-zasocitinib-wins-fda-priority-review-in-bid-to-redefine-oral-psoriasis-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630993","title":"Humanwell Healthcare Gets China Nod for Phloroglucinol Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630993","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630993?lang=en_us&edition=fundamental","pubTime":"2026-09-14 13:58","pubTimestamp":1789365504,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare  controlled unit Jiulong Renfu obtained drug registration from China's medical products regulator for phloroglucinol orally disintegrating tablets.The drug treats acute spasmodic pain from digestive, biliary, urinary and gynecological conditions, according to a weekend filing with the Shanghai bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK4137","BK4585","XBI","XLV","BK0188","BK4581","BK4588","HCSG","LU0128526141.USD","BK0096","BK0012","600079","BK0239","BK0185","LABU","LU0029874061.USD","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630333","title":"Yantai Dongcheng Pharmaceutical's Sino Siam Biotechnique Gets US FDA's EIR After Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630333","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630333?lang=en_us&edition=fundamental","pubTime":"2026-09-14 13:41","pubTimestamp":1789364503,"startTime":"0","endTime":"0","summary":"Sino Siam Biotechnique Company, a subsidiary of Yantai Dongcheng Pharmaceutical Group (SHE:002675), has received the US Food and Drug Administration's establishment inspection report following a succe","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","002675","LABU","BK0239","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667007632","title":"Aurobindo Pharma's API Unit Gets Zero Observations From US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667007632","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667007632?lang=en_us&edition=fundamental","pubTime":"2026-09-14 12:24","pubTimestamp":1789359892,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma  said a US Food and Drug Administration inspection of its Unit-IV API manufacturing facility in Andhra Pradesh, India, concluded with zero observations.The inspection was conducted from Sept. 7 to Sept. 11 at the facility operated by wholly owned subsidiary Apitoria Pharma, according to an Indian bourse filing by the pharma company.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6100","BK6520","LABU","BK4585","OTX.SI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667963250","title":"Fisher & Paykel Healthcare Lists Additional Shares on ASX as Foreign Exempt NZX Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2667963250","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667963250?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:02","pubTimestamp":1789354964,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an announcement. Fisher & Paykel Healthcare Corporation Limited has appl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-lists-additional-shares-on-asx-as-foreign-exempt-nzx-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-lists-additional-shares-on-asx-as-foreign-exempt-nzx-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FNZ.NZ","NZG.NZ","XBI","XLV","BK4585","NZ50G.NZ","NZX.NZ","BK8020","TNZ.NZ","NZT.NZ","BK4581","BK8004","LABU","T10G.NZ","BK4588","FPH.NZ","NZ20C.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667563433","title":"ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2667563433","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667563433?lang=en_us&edition=fundamental","pubTime":"2026-09-14 10:38","pubTimestamp":1789353499,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced 1% at midday Monday.CSL (ASX:CSL) gained nearly 2% in recent trade.On the flip side, the materials sector struggled, shedding nearly 1%.BHP Group (ASX:BHP) shares fell past 1% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","BK4588","BK4137","BK7095","BK4581","BK7507","BHP.AU","CSL.AU","BK7511","BK7501","BK7508","XBI","BK7067","LABU","UYM","LU0029874061.USD","HCSG","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631557","title":"Malaysia's Healthcare Sector Could Remain Resilient in 2H","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631557?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:55","pubTimestamp":1789350900,"startTime":"0","endTime":"0","summary":"0155 GMT - Malaysia's healthcare sector is expected to sustain its momentum in 2H, with patient volumes and revenue per patient continuing to improve, Affin Hwang IB analyst Andrew Lim says in a note. Hospital operators are expected to benefit from resilient healthcare demand, while regulatory risks appear more manageable, he says. The government's medical assistance program is focused on improving access to affordable private healthcare. The diagnosis-related group system could be delayed to 2028 and appears likely to adopt a gradual or hybrid fee-for-service model rather than outright fixed pricing, which could reduce the risk of a sharp impact on hospital profitability, he reckons. Affin Hwang maintains an overweight rating on Malaysia's healthcare sector, pegging IHH Healthcare as its top pick.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","HCSG","Q0F.SI","LABU","BK6511","BK4588","XBI","BK4550","TCAF","BK4585","IXJ","CGCV","NOBL","BK6092","XLV","LU0128526141.USD","BK4581","VHT","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663904","title":"Regis Healthcare Director Increases Indirect Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663904","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663904?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:37","pubTimestamp":1789349833,"startTime":"0","endTime":"0","summary":"Regis Healthcare Ltd. ( ($AU:REG) ) has provided an announcement. Regis Healthcare has disclosed changes in the indirect shareholdings of director ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-director-increases-indirect-shareholding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-healthcare-director-increases-indirect-shareholding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XLV","BK4137","LABU","BK4585","LU0029874061.USD","BK4581","XBI","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639042","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Scholar Rock Holding (SRRK) and Danaher (DHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639042","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667639042?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:30","pubTimestamp":1789349409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Summit Therapeutics (SMMT), Scholar Rock Holding (SR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-scholar-rock-holding-srrk-and-danaher-dhr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-scholar-rock-holding-srrk-and-danaher-dhr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2063271972.USD","XBI","LU1923621640.USD","LU0187121727.USD","DHR","HCSG","LABU","BK4534","LU2023250504.SGD","LU2211814178.USD","LU0820561818.USD","LU2125910336.SGD","LU0708995401.HKD","LU0289960550.SGD","FMED","IE00BQXX3F31.USD","BK4581","LU0943347566.SGD","LU1974910355.USD","LU0289739343.SGD","LU2112291526.USD","LU0511384066.AUD","BK4121","LU1791710582.SGD","LU0029874061.USD","LU0109391861.USD","LU1061106388.HKD","IBRN","LU1267930730.SGD","BK4588","LU2125909247.SGD","LU0320765059.SGD","LU2265009873.SGD","LU1804176565.USD","SRRK","IE00BKVL7J92.USD","BK4585","LU0312595415.SGD","LU0528227936.USD","LU1057294990.SGD","THNR","XLV","LU0097036916.USD","SMMT","SGXZ57979304.SGD","LU2125909593.SGD","LU0114720955.EUR","LU0820562030.AUD","IE00BQXX3D17.EUR","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639428","title":"HealthCo Healthcare and Wellness REIT Says Healthscope Lender Support Obtained for Transfer of 10 Hospitals","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639428","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667639428?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:27","pubTimestamp":1789349269,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT  said the requisite support has been obtained from Healthscope's lenders for the transfer of 10 Healthscope hospitals owned by the company and the Unlisted Healthcare Fund to alternative hospital operators, according to a Monday filing with the Australian bourse.The commercial terms of the proposed transaction, which is subject to customary approvals, are consistent with HealthCo's previous disclosures, the company said.It added that Healthscope remains compliant with lease obligations and has paid all of the rent due through September.The transfer will provide continuity of healthcare services across the hospitals while maintaining jobs for nurses and staff, HealthCo Healthcare said.The company's shares gained 1% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCW.AU","BPRE","LABU","BK4137","XLV","JJJ.SI","XBI","DFRA","HCSG","RJMG","YLDW","MDIV","CFA.SI","SRT.SI","BK7149","BK4581","IQRA","LU0029874061.USD","LU0128526141.USD","BK4585","IVRA","SRU.SI","BK6142","RNTY","BK7156","8C8U.SI","BK4588","PSCF","GLS.SI","CLR.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639921","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667639921?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:20","pubTimestamp":1789348809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Faeth Therapeutics (FTH), 4D Molecular Therapeutics ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-337?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-337?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","XLV","BK4585","LU0029874061.USD","XBI","LABU","FTH","LU0128526141.USD","BK4588","HCSG","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168235511","title":"160 Health Expands into Integrated Healthcare and AI Computing Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=1168235511","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168235511?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:14","pubTimestamp":1789341258,"startTime":"0","endTime":"0","summary":"160 Health (02656) has announced that its domestic subsidiary has successfully delivered an integrated solution valued at RMB 12.2 million to a health-focused enterprise specializing in smart...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IXJ","WISE","BK4550","BK4588","159760","BK1197","02656","BK4581","VHT","XLV","WDAI","AIO","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":7,"totalSize":411,"code":"91000000","status":"200"}]}}